RxDoctor Payments Data

Heather Hyden

Family · Winchester, TNNPI 1285292581

Payments from drug & device makers

$3,755in general payments, 2019–2025

Across 197 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$720
  • Novartis$696
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$517
  • Johnson & Johnson$494
  • AstraZeneca$317
  • Merck$285
  • plus $725 from 14 others

What the payments were for

  • Travel & lodging$2065%
  • Food & beverage$3,52794%
  • Education$221%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,755 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$120,153
Medicare patients
649
Services billed
2,863

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban310$302,101
XareltoRivaroxaban192$210,210
EntrestoSacubitril/Valsartan117$162,140
FarxigaDapagliflozin Propanediol22$25,681
Ranolazine ErRanolazine77$14,261
BrilintaTicagrelor14$9,670
Flecainide Acetate182$9,639
Valsartan65$6,976
Icosapent Ethyl14$5,089
Rosuvastatin Calcium302$4,600
Propafenone Hcl63$4,584
Clonidine18$3,787
Amiodarone Hcl212$3,782
Isosorbide Mononitrate ErIsosorbide Mononitrate224$3,680
Losartan Potassium225$3,533

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$82$302,101310 claims
Johnson & JohnsonXarelto$494$210,210192 claims
NovartisEntresto$696$162,140117 claims
AstraZenecaFarxiga, Brilinta$317$35,35136 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.

Other family in Winchester

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →